Jenkem Technology (688356.SH) stated on the investor interaction platform on August 2 that fatty acid side chains can be used for the modification of various peptide-based drugs. The company can provide various fatty acid side chain products with different structures and can customize the structure based on customer needs. Currently, the such R&D projects supported by Jenkem Technology are in the early stage of research and development. There are many factors involved in pharmaceutical R&D, and uncertainties are also more, please pay attention to investment risks. The company will closely monitor industry trends and technological innovations and plan the layout of relevant products according to market demand and the company's actual situation.